Literature DB >> 27022031

Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice.

Kouichi Miura1, Mitsuaki Ishioka2, Shinichiro Minami2, Yasuo Horie2, Shigetoshi Ohshima2, Takashi Goto2, Hirohide Ohnishi2.   

Abstract

The role of Toll-like receptor (TLR) signaling has attracted much attention in the development of hepatic inflammation and hepatocellular carcinoma (HCC). We herein sought to determine the role of TLRs and responsible cells in steatohepatitis-related HCC. We used hepatocyte-specific Pten-deficient (Pten(Δ) (hep)) mice, which exhibit steatohepatitis followed by liver tumor formation, including HCC. We then generated Pten(Δ) (hep)/Tlr4(-/-) and Pten(Δ) (hep)/Tlr2(-/-) double-mutant mice and investigated the role of macrophages using reconstitution of bone marrow (BM)-derived cells, chemical depletion of macrophages, and isolated macrophages. Tlr4 but not Tlr2 deficiency in the Pten(Δ) (hep) mice suppressed tumor growth as well as hepatic inflammation. Gut sterilization by an antibiotic mixture reduced the portal LPS levels as well as tumor growth in the Pten(Δ) (hep) mice. Tumor growth was also decreased by reconstitution of BM-derived cells to Tlr4(-/-) BM cells. In addition, chemical depletion of macrophages significantly reduced tumor size and numbers. Macrophages expressing Ly6C were increased in number, which was associated with inflammation and tumor progression in the Pten(Δ) (hep) mice. Hepatic macrophages isolated from the Pten(Δ) (hep) mice abundantly expressed the Ly6C gene and produced much more IL-6 and TNFα in response to LPS. These proinflammatory cytokines induced the proliferation of HCC cells as well as oval cells, putative cancer progenitor cells. Indeed, putative cancer progenitor cells emerged before the development of macroscopic liver tumors and then increased in number under sustained inflammation. TLR4 on macrophages contributes to the development of steatohepatitis-related HCC in mice.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  hepatocellular carcinoma; inflammation; macrophage; phosphatase and tensin homolog (PTEN); toll-like receptor (TLR)

Mesh:

Substances:

Year:  2016        PMID: 27022031      PMCID: PMC4882422          DOI: 10.1074/jbc.M115.709048

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.

Authors:  Seth Rakoff-Nahoum; Justin Paglino; Fatima Eslami-Varzaneh; Stephen Edberg; Ruslan Medzhitov
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

2.  Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation.

Authors:  I Kirillova; M Chaisson; N Fausto
Journal:  Cell Growth Differ       Date:  1999-12

3.  Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis.

Authors:  K Tarao; Y Rino; S Ohkawa; A Shimizu; S Tamai; K Miyakawa; H Aoki; T Imada; K Shindo; N Okamoto; S Totsuka
Journal:  Cancer       Date:  1999-08-15       Impact factor: 6.860

4.  Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

Authors:  H Yoshida; Y Shiratori; M Moriyama; Y Arakawa; T Ide; M Sata; O Inoue; M Yano; M Tanaka; S Fujiyama; S Nishiguchi; T Kuroki; F Imazeki; O Yokosuka; S Kinoyama; G Yamada; M Omata
Journal:  Ann Intern Med       Date:  1999-08-03       Impact factor: 25.391

5.  Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC.

Authors:  K Tarao; S Takemiya; S Tamai; Y Sugimasa; S Ohkawa; M Akaike; H Tanabe; A Shimizu; M Yoshida; A Kakita
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

6.  Direct effects of interleukin-6 on liver progenitor oval cells in culture.

Authors:  Vance B Matthews; Elizabeth Klinken; George C T Yeoh
Journal:  Wound Repair Regen       Date:  2004 Nov-Dec       Impact factor: 3.617

7.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

8.  Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.

Authors:  Yasuo Horie; Akira Suzuki; Ei Kataoka; Takehiko Sasaki; Koichi Hamada; Junko Sasaki; Katsunori Mizuno; Go Hasegawa; Hiroyuki Kishimoto; Masahiro Iizuka; Makoto Naito; Katsuhiko Enomoto; Sumio Watanabe; Tak Wah Mak; Toru Nakano
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

9.  Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.

Authors:  Laszlo Romics; Angela Dolganiuc; Karen Kodys; Yvonne Drechsler; Shilpa Oak; Arumugam Velayudham; Pranoti Mandrekar; Gyongyi Szabo
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

10.  Tlr2 is critical for diet-induced metabolic syndrome in a murine model.

Authors:  Ryan W Himes; C Wayne Smith
Journal:  FASEB J       Date:  2009-10-19       Impact factor: 5.191

View more
  20 in total

1.  Prognostic impact of toll-like receptors 2 and 4 expression on monocytes in Egyptian patients with hepatocellular carcinoma.

Authors:  Asmaa M Zahran; Zeinab Albadry M Zahran; Omnia El-Badawy; Mona H Abdel-Rahim; Wageeh A M Ali; Amal Rayan; Muhammad Abbas El-Masry; Mohamed A A Abozaid; Helal F Hetta
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

2.  LPS induces HUVEC angiogenesis in vitro through miR-146a-mediated TGF-β1 inhibition.

Authors:  Yize Li; Huayu Zhu; Xu Wei; Heng Li; Zhicao Yu; Hongmei Zhang; Wenchao Liu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

3.  Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.

Authors:  Mitsuaki Ishioka; Kouichi Miura; Shinichiro Minami; Yoichiro Shimura; Hirohide Ohnishi
Journal:  Dig Dis Sci       Date:  2016-12-02       Impact factor: 3.199

4.  Toll-Like Receptor 4 Regulates Rabies Virus-Induced Humoral Immunity through Recruitment of Conventional Type 2 Dendritic Cells to Lymph Organs.

Authors:  Chen Chen; Chengguang Zhang; Haoqi Li; Zongmei Wang; Yueming Yuan; Ming Zhou; Zhen F Fu; Ling Zhao
Journal:  J Virol       Date:  2021-10-06       Impact factor: 5.103

5.  Design and optimisation of a small-molecule TLR2/4 antagonist for anti-tumour therapy.

Authors:  Qun Xu; Tian Li; Hekai Chen; Jun Kong; Liwei Zhang; Hang Yin
Journal:  RSC Med Chem       Date:  2021-09-07

6.  Influence of vitamin D on cancer risk and treatment: Why the variability?

Authors:  M Rita I Young; Ying Xiong
Journal:  Trends Cancer Res       Date:  2018

7.  Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high-fat diet.

Authors:  Kouichi Miura; Hirohide Ohnishi; Naoki Morimoto; Shinichiro Minami; Mitsuaki Ishioka; Shunji Watanabe; Mamiko Tsukui; Yoshinari Takaoka; Hiroaki Nomoto; Norio Isoda; Hironori Yamamoto
Journal:  Cancer Sci       Date:  2019-01-09       Impact factor: 6.716

8.  Th17 Cells in Protection from Tumor or Promotion of Tumor Progression.

Authors:  M Rita I Young
Journal:  J Clin Cell Immunol       Date:  2016-06-20

Review 9.  Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma.

Authors:  Kazuki Takakura; Tsunekazu Oikawa; Yoichi Tomita; Yusuke Mizuno; Masanori Nakano; Chisato Saeki; Yuichi Torisu; Masayuki Saruta
Journal:  World J Gastroenterol       Date:  2018-05-14       Impact factor: 5.742

10.  Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis.

Authors:  Jennifer Nguyen; Jingjing Jiao; Kristin Smoot; Gordon P Watt; Chen Zhao; Xingzhi Song; Heather L Stevenson; Joseph B McCormick; Susan P Fisher-Hoch; Jianhua Zhang; P Andrew Futreal; Laura Beretta
Journal:  Oncotarget       Date:  2018-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.